Testing effectiveness (Phase 2)Not Yet RecruitingNCT06684873
What this trial is testing
A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)
Who this might be right for
NSCLCBrain Metastasases
Sun Yat-sen University 55